3.6  In conclusion

Table 3.5 summarises the current and forthcoming antiviral EPI vaccines in Ethiopia.

Table 3.5  Summary of antiviral vaccines in the EPI in Ethiopia.
VaccineProtects againstDoses/whenRoute
HepBHepatitis BThree: at 6, 10 and 14 weeks, in the pentavalent vaccineIntramuscular, upper outer left thigh
OPVPoliomyelitisFour: at birth, then at 6, 10 and 14 weeks (additional campaign doses may be given)Oral (drops into the mouth)
MeaslesMeaslesOne: at 9 months, or as soon as possible thereafter (plus one additional campaign dose)Subcutaneous, outer upper arm
RotavirusRotavirus diarrhoeaTwo: at 6 and 10 weeks (but first dose no later than 12 weeks, second dose no later than 24 weeks, with an interval of at least 4 weeks between doses)Oral (drops into the mouth)

3.5  Yellow fever vaccine

Summary of Study Session 3